feed,title,long_url,short_url
InsiderMonkey,Jim Cramer’s Recent Responses to Questions About 12 Stocks,https://insidermonkey.com/blog/--1650786,
InsiderMonkey,16 Stocks Jim Cramer Recently Talked About,https://insidermonkey.com/blog/--1651248,
InsiderMonkey,Jim Cramer on Circle Internet: “It Could Be an Even Bigger Winner”,https://insidermonkey.com/blog/--1650796,
InsiderMonkey,Jim Cramer Still Calls CoreWeave’s Stock Price a “Win” Despite Being Significantly Down From Its Peak,https://insidermonkey.com/blog/--1650800,
InsiderMonkey,Jim Cramer Believes Venture Global “Has Been Very Disappointing”,https://insidermonkey.com/blog/--1650805,
InsiderMonkey,Jim Cramer on Kimco Realty: “I Still Like the Idea of Dividend Protection Here”,https://insidermonkey.com/blog/--1650808,
InsiderMonkey,Jim Cramer Discusses Reasons Why Six Flags Stock Got “Really Obliterated”,https://insidermonkey.com/blog/--1650813,
InsiderMonkey,Jim Cramer Says “The Biggest Winner After Google May Be Apple”,https://insidermonkey.com/blog/--1650815,
InsiderMonkey,Jim Cramer Says “Meta’s Been Quiet”,https://insidermonkey.com/blog/--1650817,
InsiderMonkey,Jim Cramer Says “Tesla’s Now About Elon Musk’s Vision of Self-Driving Cars and Robots”,https://insidermonkey.com/blog/--1650819,
InsiderMonkey,Jim Cramer on Amazon: “I Think the Doubters Are Wrong”,https://insidermonkey.com/blog/--1650821,
InsiderMonkey,Jim Cramer Says Oracle “Can Get Lots of Takers for Its Product”,https://insidermonkey.com/blog/--1650825,
InsiderMonkey,Jim Cramer on NVIDIA: “Anything That Allows the Company to Sell in China Would Be Huge”,https://insidermonkey.com/blog/--1650823,
InsiderMonkey,Jim Cramer Highlights and Discusses Alphabet’s New Version of Gemini Generative AI Platform,https://insidermonkey.com/blog/--1650827,
InsiderMonkey,Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Result,https://insidermonkey.com/blog/--1652255,
InsiderMonkey,Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results,https://insidermonkey.com/blog/--1652256,
InsiderMonkey,CX-2051 Momentum and An Expanding Oncology Pipeline Strengthen CytomX Therapeutics’ (CTMX) Investment Case,https://insidermonkey.com/blog/--1652257,
InsiderMonkey,Gain Therapeutics’ (GANX) Preclinical Momentum Drives Its Progress in Parkinson’s Drug Development,https://insidermonkey.com/blog/--1652258,
InsiderMonkey,Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement,https://insidermonkey.com/blog/--1652259,
InsiderMonkey,Veritone’s (VERI) Debt Discipline and AI Expansion Drive Its Evolving Growth Story,https://insidermonkey.com/blog/--1652260,
